Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions.

Tim E PhelpsEnis C YilmazStephanie A HarmonMason J BelueJoanna H ShihCharisse GarciaLindsey A HazenAntoun ToubajiMaria J MerinoSandeep GurramPeter L ChoykeBradford J WoodPeter A PintoIsmail Baris Turkbey

Published in: Abdominal radiology (New York) (2022)

Reduced-core prostate biopsy strategies confined to the ipsilateral hemigland underestimate csPCa burden by at least 8% in patients with unilateral mpMRI-visible intraprostatic lesions. The combined TBx + SBx strategy maximizes csPCa detection.

Keyphrases

prostate cancer
benign prostatic hyperplasia
ultrasound guided
fine needle aspiration
papillary thyroid
squamous cell
risk factors
loop mediated isothermal amplification
label free
squamous cell carcinoma
childhood cancer